{
    "2020-05-27": [
        [
            {
                "time": "2021-03-15",
                "original_text": "The Zacks Analyst Blog Highlights: Novavax, Moderna, Pfizer, Gilead and Vir Biotechnology",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst Blog",
                        "Novavax",
                        "Moderna",
                        "Pfizer",
                        "Gilead",
                        "Vir Biotechnology"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-20",
                "original_text": "Merck Inks 3 Deals for Coronavirus Anti-infective & Vaccines",
                "features": {
                    "keywords": [
                        "Merck",
                        "Deals",
                        "Coronavirus",
                        "Anti-infective",
                        "Vaccines"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-10",
                "original_text": "Pharma exports a rare bright spot for Singapore economy as pandemic drives demand",
                "features": {
                    "keywords": [
                        "Pharma",
                        "exports",
                        "Singapore",
                        "economy",
                        "pandemic",
                        "demand"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "economy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}